KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Capital Leases (2016 - 2021)

Neogenomics' Capital Leases history spans 12 years, with the latest figure at $71000.0 for Q4 2021.

  • For Q4 2021, Capital Leases fell 92.66% year-over-year to $71000.0; the TTM value through Dec 2021 reached $71000.0, down 92.66%, while the annual FY2021 figure was $71000.0, 92.66% down from the prior year.
  • Capital Leases reached $71000.0 in Q4 2021 per NEO's latest filing, down from $152000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $11.5 million in Q4 2018 to a low of $71000.0 in Q4 2021.
  • Average Capital Leases over 5 years is $4.1 million, with a median of $4.3 million recorded in 2017.
  • Peak YoY movement for Capital Leases: skyrocketed 96.02% in 2017, then tumbled 92.66% in 2021.
  • A 5-year view of Capital Leases shows it stood at $10.5 million in 2017, then increased by 9.54% to $11.5 million in 2018, then crashed by 72.3% to $3.2 million in 2019, then tumbled by 69.77% to $967000.0 in 2020, then crashed by 92.66% to $71000.0 in 2021.
  • Per Business Quant, the three most recent readings for NEO's Capital Leases are $71000.0 (Q4 2021), $152000.0 (Q3 2021), and $448000.0 (Q2 2021).